KORU Medical Systems (KRMD) EBIT Margin (2010 - 2026)

KORU Medical Systems' EBIT Margin history runs 12 years deep, the most recent figure standing at 7.35% for Q1 2026.

• In Q1 2026, EBIT Margin rose 557.0% year-over-year to 7.35%; the TTM figure through Mar 2026 stood at 2.15% (up 1848.0% YoY), while the FY2025 annual figure was 1.34%, up 2049.0% from the prior year.
• EBIT Margin was 7.35% for Q1 2026 at KORU Medical Systems, down from 27.3% in the prior quarter.
• In the past five years, EBIT Margin ranged from a high of 27.3% in Q4 2025 to a low of 55.2% in Q2 2022.
• Historically, EBIT Margin has averaged 22.61% across 5 years, with a median of 20.82% in 2024.
• The sharpest annual moves came in 2022 and 2025: EBIT Margin tumbled 13053 bps in 2022, then surged 4529 bps in 2025.
• A 5-year view of EBIT Margin shows it stood at 34.19% in 2022, then increased by 11 bps to 30.58% in 2023, then soared by 41 bps to 17.98% in 2024, then soared by 252 bps to 27.3% in 2025, then slumped by 127 bps to 7.35% in 2026.
• The last three EBIT Margin figures came in at 7.35% (Q1 2026), 27.3% (Q4 2025), and 8.34% (Q3 2025), per Business Quant data.